SEMA3F and lung cancer: In H157 lung cancer cells, sema3F inhibited multiple signaling pathways including Protein kinase B (AKT)/Signal transducer and activator of transcription 3 (STAT3) signaling resulting in the loss of activated αvβ3-integrin [141,142].